An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Candidiasis, OralHIV Infections
Interventions
DRUG

Itraconazole

Trial Locations (18)

19107

Pennsylvania Hosp, Philadelphia

20009

Dr Douglas Ward, Washington D.C.

20037

George Washington Univ Med Ctr, Washington D.C.

20422

Veterans Administration Med Ctr, Washington D.C.

20892

Natl Inst of Allergy & Infect Dis / Cln Ctr, Bethesda

22908

Univ of Virginia Health Sciences Ctr, Charlottesville

35294

Univ of Alabama at Birmingham, Birmingham

37212

Infectious Disease Clinic, Nashville

43210

Ohio State Univ Hosp, Columbus

46202

Infectious Diseases Research Clinic / Indiana Univ Hosp, Indianapolis

48105

Ann Arbor Veterans Administration Med Ctr, Ann Arbor

48201

Wayne State Univ / Harper Hosp, Detroit

63108

Washington Univ, St Louis

72205

Univ of Arkansas for Med Sciences, Little Rock

73104

Oklahoma City Veterans Administration Med Ctr, Oklahoma City

78284

Audie L Murphy Veterans Administration Hosp, San Antonio

94115

Kaiser Permanente Med Ctr, San Francisco

94705

East Bay AIDS Ctr, Berkeley

All Listed Sponsors
lead

Janssen, LP

INDUSTRY

NCT00002133 - An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects. | Biotech Hunter | Biotech Hunter